Archives for April 24, 2018

← 2018

STA to manufacture PhoenixMD candidate for Ph I study

By Melissa Fassbender

STA Pharmaceutical is manufacturing PhoenixMD’s kinase inhibitor drug candidate for IND-enabling toxicology studies and a Phase I study in women with triple-negative breast cancer.

Letter to the editor

Sizing up: Does CRO consolidation leave space for smaller firms?

By Melissa Fassbender

A continued need for specialized services and expertise will keep smaller firms in business – though many have forecasted the “death of small- to mid-sized CROs” as the industry continues to consolidate, say experts.